Today's News | Note: News feeds may no longer be available for the articles on this page.

Pfizer Bid May Spur Drug Consolidation as Glaxo, Bayer Go Solo 6:50 AM 1/25/2009
Bloomberg - USA
Pfizer Inc’s potential purchase of Wyeth may set off a rush to consolidate in an industry with thin pipelines of new products, generic competition, and more hostile regulator. ...

Biogen shares fall on MS drug competitive outlook 4:13 PM 1/23/2009
Forbes - NY,USA
Merck KGaA plans on asking for approval of its multiple sclerosis drug cladribine in the middle of 2009. Biogen Idec makes the multiple sclerosis drug Tysabri. ...

Stem cell human trials planned 11:52 AM 1/23/2009
Forbes - NY,USA
The first human clinical trials of a stem cell drug candidate are being planned by Geron Corp for GRNOPC1. The company has an IND for severe spinal cord injuries. ...

European Drug Shares Up On Pfizer Talk, But No Big Deals Seen 6:06 AM 1/23/2009
CNNMoney.com - USA
European pharmaceutical stocks benefited from news Pfizer Inc is in takeover talks with smaller rival Wyeth. Analysts caution that an eventual deal won't begin new round of mergers in the sector. ...

Glaxo Buys UCB's Older Drugs In Emerging Mkts 5:36 AM 1/23/2009
Wall Street Journal - USA
GlaxoSmithKline signed a deal with UCB SA to purchase older drugs in emerging countries. ...

Daiichi Sankyo to seek approval of influenza drug 5:33 AM 1/23/2009
Reuters - USA
Daiichi Sankyo Co plans to apply by March 2010 for marketing approval in Japan of influenza drug candidate CS-8958. ...

J&J Psoriasis Drug Wins European Approval, Awaits US Review 4:23 PM 1/22/2009
Bloomberg - USA
European Union regulators cleared the use of Johnson & Johnson's ustekinumab in psoriasis patients who aren’t helped by other treatments. ...

Report cites FDA's weaknesses over drugs, devices 2:32 PM 1/22/2009
Reuters - USA
The American consumer may not be adequately protected from unsafe and ineffective medical products. ...

EU agency warns of heart risk with Orion drug 1:02 PM 1/22/2009
Reuters - USA
Orion's breast cancer drug Fareston (toremifene) should not be used in patients with heart conditions at risk of prolonged QT intervals or other heart problems. ...

Patent challenge threatens Inspire's sales 12:32 PM 1/22/2009
Bizjournals.com - Charlotte,NC,USA
Inspire Pharmaceuticals faces challenges from three companies that want to sell a generic of the allergy drug Elestat. Inspire co-promotes Elestat for allergic conjunctivitis under a deal with Allergan. ...

EU body recommends Teva's generic hepatitis C drug 11:56 AM 1/22/2009
Reuters - USA
Israel's Teva Pharmaceutical Industries has won backing from European regulators for its hepatitis C drug Ribavirin Teva. It's a generic version of Schering-Plough Corp's Rebetol. ...

No injuries in blast at Mylan drug lab in W.Va. 11:36 AM 1/22/2009
BusinessWeek - USA
The blast occurred in one of the processing rooms around midnight. Emergency responders did not know what caused the explosion. ...

Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat 1:23 AM 1/22/2009
MSNBC - USA
Myriad Pharmaceuticals Inc has acquired all rights to bevirimat from Panacos Pharmaceuticals, Inc for $7M. ...

King Pharma slides on Skelaxin patent verdict 12:26 PM 1/21/2009
Forbes - NY,USA
King Pharmaceuticals Inc said two of the three patents protecting its top-selling drug Skelaxin were overturned. The challenge was brought by Eon Labs looking to market a generic version. ...

EU Approves Roche's Rheumatoid-Arthritis Drug 12:09 PM 1/21/2009
Wall Street Journal - USA
The European Union gave Roche approval to sell its rheumatoid-arthritis drug RoActemra. ...

<- Day Earlier | Today's News